Colorectal cancer and lymph nodes: The obsession with the number 12
Open Access
- 1 January 2014
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (8) , 1951-1960
Abstract
Lymphadenectomy of colorectal cancer is a decisive factor for the prognostic and therapeutic staging of the patient. For over 15 years, we have asked ourselves if the minimum number of 12 examined lymph nodes (LNs) was sufficient for the prevention of understaging. The debate is certainly still open if we consider that a limit of 12 LNs is still not the gold standard mainly because the research methodology of the first studies has been criticized. Moreover many authors report that to date both in the United States and Europe the number "12" target is uncommon, not adequate, or accessible only in highly specialised centres. It should however be noted that both the pressing nature of the debate and the dissemination of guidelines have been responsible for a trend that has allowed for a general increase in the number of LNs examined. There are different variables that can affect the retrieval of LNs. Some, like the surgeon, the surgery, and the pathology exam, are without question modifiable; however, other both patient and disease-related variables are non-modifiable and pose the question of whether the minimum number of examined LNs must be individually assigned. The lymph nodal ratio, the sentinel LNs and the study of the biological aspects of the tumor could find valid application in this field in the near future.Keywords
This publication has 100 references indexed in Scilit:
- The Impact of Age on Quality Measure Adherence in Colon CancerJournal of the American College of Surgeons, 2011
- The impact of audit and feedback on nodal harvest in colorectal cancerBMC Cancer, 2011
- Variation in Lymph Node Assessment After Colon Cancer Resection: Patient, Surgeon, Pathologist, or Hospital?Journal of Gastrointestinal Surgery, 2010
- Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trialThe Lancet Oncology, 2010
- Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report CardJNCI: Journal of the National Cancer Institute, 2008
- More Extensive Nodal Dissection Improves Survival for Stages I to III of Colon CancerTransactions of the ... Meeting of the American Surgical Association, 2006
- Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trialThe Lancet Oncology, 2005
- Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trialThe Lancet, 2005
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Lymph Node Recoveries From 2427 pT3 Colorectal Resection Specimens Spanning 45 YearsAmerican Journal of Surgical Pathology, 2002